Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy

Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy

Abstract Background For patients with locally advanced nasopharyngeal cancer (LA-NPC), concurrent chemoradiotherapy (CCRT) is the standardized treatment. However, whether a weekly or triweekly cisplatin regimen should be used during CCRT is controversial. Therefore, we conducted this meta-analysis t...

Full description

Bibliographic Details
Main Authors: Xin Li, Lei Li, Ruimei Sun, Jingyan Gao, Zhengfei Li, Yongyuan Xue, Lixiu Zhu, Tianrui Xu, Chuanzheng Sun, Yan Xi, Wei Xiong
Format: Article
Language:English
Published: BMC 2023-10-01
Series:European Journal of Medical Research
Subjects:
Nasopharyngeal cancer
Concurrent chemoradiotherapy
Cisplatin
Meta-analysis
Online Access:https://doi.org/10.1186/s40001-023-01297-y

Internet

https://doi.org/10.1186/s40001-023-01297-y

Similar Items